Atria Wealth Solutions’s BioLineRX BLRX Stock Holding History

Atria Wealth Solutions’s Portfolio BLRX Stock Details BLRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,353	Closed	-$20.1K	–	1883
2024 Q4	$20.1K	Hold	2,353	–	–	﹤0.01%	1957
2024 Q3	$50.5K	Sell	2,353 -130	-5%	-$3.57K	﹤0.01%	1888
2024 Q2	$56.6K	Hold	2,483	–	–	﹤0.01%	1883
2024 Q1	$111K	Sell	2,483 -276	-10%	-$13.8K	﹤0.01%	1883
2023 Q4	$173K	Hold	2,759	–	–	﹤0.01%	1802
2023 Q3	$201K	Hold	2,759	–	–	﹤0.01%	1703
2023 Q2	$176K	Hold	2,759	–	–	﹤0.01%	1731
2023 Q1	$97.8K	Sell	2,759 -75	-3%	-$1.97K	﹤0.01%	1762
2022 Q4	$66.9K	Buy	2,834 +233	+9%	+$6.93K	﹤0.01%	1722
2022 Q3	$96.2K	Hold	2,601	–	–	﹤0.01%	1642
2022 Q2	$133K	Hold	2,601	–	–	﹤0.01%	1507
2022 Q1	$178K	Buy	+2,601	New	+$181K	﹤0.01%	1616

Other funds holding BLRX

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

NRG

Nemes Rush Group Novi, Michigan $1.05B AUM 30.08% 1-Year Est. Return

NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Atria Wealth Solutions's BLRX Position: Q1 2025 in Review

Atria Wealth Solutions sold out of BioLineRX (BLRX) in Q1 2025, closing a stake of 2,353 shares — an estimated $20.1K sold.

Atria Wealth Solutions first reported a position in BLRX in Q1 2022 and held it in 12 quarters. The position peaked at $201K in Q3 2023. 12 funds tracked by Wall St. Rank hold BLRX as of Q1 2025.

Atria Wealth Solutions reported no remaining BioLineRX position as of Q1 2025 after selling out during the quarter.
Atria Wealth Solutions sold 2,353 BioLineRX shares in Q1 2025, an estimated $20.1K.
Atria Wealth Solutions first reported a position in BioLineRX in Q1 2022 and held it in 12 quarters.
Atria Wealth Solutions's BioLineRX position peaked at $201K in Q3 2023.
12 funds tracked by Wall St. Rank held BioLineRX as of Q1 2025.

Based on Atria Wealth Solutions's 13F filing for Q1 2025, filed 9 May 2025.